1,317
Views
81
CrossRef citations to date
0
Altmetric
Reviews

Toll-like receptor modulators: a patent review (2006 – 2010)

, , , &
Pages 927-944 | Published online: 15 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Madeleine E. Kieffer, Akash M. Patel, Scott A. Hollingsworth & W. Michael Seganish. (2020) Small molecule agonists of toll-like receptors 7 and 8: a patent review 2014 – 2020. Expert Opinion on Therapeutic Patents 30:11, pages 825-845.
Read now
Chhedi Lal Gupta, Mohd. Babu Khan, Dinakara Rao Ampasala, Salman Akhtar, Upendra Nath Dwivedi & Preeti Bajpai. (2019) Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7. Journal of Biomolecular Structure and Dynamics 37:18, pages 4721-4736.
Read now
Hesam Dorosti, Mahboobeh Eslami, Manica Negahdaripour, Mohammad Bagher Ghoshoon, Ahmad Gholami, Reza Heidari, Ali Dehshahri, Nasrollah Erfani, Navid Nezafat & Younes Ghasemi. (2019) Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine. Journal of Biomolecular Structure and Dynamics 37:13, pages 3524-3535.
Read now
Marion Dajon, Kristina Iribarren, Florent Petitprez, Solenne Marmier, Audrey Lupo, Mélanie Gillard, Hanane Ouakrim, Navas Victor, Di Bartolo Vincenzo, Pierre Emmanuel Joubert, Oliver Kepp, Guido Kroemer, Marco Alifano, Diane Damotte & Isabelle Cremer. (2019) Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells. OncoImmunology 8:1.
Read now
Mahesh Chandra Patra & Sangdun Choi. (2016) Recent progress in the development of Toll-like receptor (TLR) antagonists. Expert Opinion on Therapeutic Patents 26:6, pages 719-730.
Read now
Amin Zakeri, Hassan Borji & Alireza Haghparast. (2016) Interaction Between Helminths and Toll-Like Receptors: Possibilities and Potentials for Asthma Therapy. International Reviews of Immunology 35:3, pages 219-248.
Read now
Kais Hussein, Angelika Stucki-Koch, Hans Kreipe & Henning Feist. (2015) Expression of Toll-Like Receptors in Chronic Histiocytic Intervillositis of the Placenta. Fetal and Pediatric Pathology 34:6, pages 407-412.
Read now
Waleed M Hussein, Tzu-Yu Liu, Mariusz Skwarczynski & Istvan Toth. (2014) Toll-like receptor agonists: a patent review (2011 – 2013). Expert Opinion on Therapeutic Patents 24:4, pages 453-470.
Read now

Articles from other publishers (73)

Feng Zeng, Ying Li, Xiaoxiao Zhang, Li Shen, Xingyu Zhao, Trust Beta, Bin Li, Rui Chen & Wuyang Huang. (2024) Immune regulation and inflammation inhibition of Arctium lappa L. polysaccharides by TLR4/NF-κB signaling pathway in cells. International Journal of Biological Macromolecules 254, pages 127700.
Crossref
Mark Uhlik, Daniel Pointing, Seema Iyer, Luka Ausec, Miha Štajdohar, Robert Cvitkovič, Matjaž Žganec, Kerry Culm, Valerie Chamberlain Santos, Bronislaw Pytowski, Mokenge Malafa, Hong Liu, Arthur M. Krieg, Jeeyun Lee, Rafael Rosengarten & Laura Benjamin. (2023) Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers. Frontiers in Oncology 13.
Crossref
Jaafar Suhail Wadi, Dunya AL-Duhaidahawi, Sarmad salam abdullah, Majid Jabir, Mazin A.A. Najim, Sabrean Farhan Jawad, Sawsan S. Hamzah & Faizan Abdul Qais. (2023) Exploring the interaction between 3-D structure of TLR 9 and prostaglandin analogues. Arabian Journal of Chemistry 16:5, pages 104692.
Crossref
Azhar Saleem Zargar, Kumudini Borole & Rohit Rai. (2023) Correlation of polymorphism in Toll-Like Receptor (TLR1 and TLR2) genes with susceptibility of pulmonary tuberculosis in Doda region of India. Indian Journal of Tuberculosis.
Crossref
Balram Ji Omar, Arpana Singh, Vanya Singh, Ashish Kothari & Manju O. Pai. (2022) SARS-CoV-2: overview of immune response, insights into vaccine platforms and their challenges. Exploration of Immunology, pages 245-263.
Crossref
Fatemeh Esmaeilzadeh & Shirin Mahmoodi. (2022) A Novel Design of Multi-epitope Peptide Vaccine Against Pseudomonas aeruginosa. Letters in Drug Design & Discovery 19:4, pages 304-313.
Crossref
Xiao Li, Xinyuan Sun, Xuemin Guo, Xueren Li, Shouchun Peng & Xin Mu. (2022) Chemical reagents modulate nucleic acid-activated toll-like receptors. Biomedicine & Pharmacotherapy 147, pages 112622.
Crossref
Shashank Vishwanath Adhikarla, Niraj Kumar Jha, Vineet Kumar Goswami, Ankur Sharma, Anuradha Bhardwaj, Abhijit Dey, Chiara Villa, Yatender Kumar & Saurabh Kumar Jha. (2021) TLR-Mediated Signal Transduction and Neurodegenerative Disorders. Brain Sciences 11:11, pages 1373.
Crossref
Paree Khokhani, Nada R. Rahmani, Anne Kok, F. Cumhur Öner, Jacqueline Alblas, Harrie Weinans, Moyo C. Kruyt & Michiel Croes. (2021) Use of Therapeutic Pathogen Recognition Receptor Ligands for Osteo-Immunomodulation. Materials 14:5, pages 1119.
Crossref
Nikolaos C. Kyriakidis, Andrés López-Cortés, Eduardo Vásconez González, Alejandra Barreto Grimaldos & Esteban Ortiz Prado. (2021) SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. npj Vaccines 6:1.
Crossref
Fahad Alotaibi, Muhammad Attique & Yaser Daanial Khan. (2021) AntiFlamPred: An Anti-Inflammatory Peptide Predictor for Drug Selection Strategies. Computers, Materials & Continua 69:1, pages 1039-1055.
Crossref
Payam Behzadi. 2021. Genetic Polymorphism and cancer susceptibility. Genetic Polymorphism and cancer susceptibility 281 317 .
Stefano Federico, Luca Pozzetti, Alessandro Papa, Gabriele Carullo, Sandra Gemma, Stefania Butini, Giuseppe Campiani & Nicola Relitti. (2020) Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. Journal of Medicinal Chemistry 63:22, pages 13466-13513.
Crossref
Asunción Espinosa-Sánchez, Elisa Suárez-Martínez, Laura Sánchez-Díaz & Amancio Carnero. (2020) Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness. Frontiers in Oncology 10.
Crossref
Mahesh Chandra Patra, Masaud Shah & Sangdun Choi. (2020) Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases. Seminars in Cancer Biology 64, pages 61-82.
Crossref
Xiong-Feng Xu, Die Hu, Bo-Chun Hu, Chuang Li, You-Yi Liu & Min-Chen Wu. (2020) Near-perfect kinetic resolution of o-methylphenyl glycidyl ether by RpEH, a novel epoxide hydrolase from Rhodotorula paludigena JNU001 with high stereoselectivity. Applied Microbiology and Biotechnology 104:14, pages 6199-6210.
Crossref
Mahesh Chandra Patra, Maria Batool, Muhammad Haseeb & Sangdun Choi. (2020) A Computational Probe into the Structure and Dynamics of the Full-Length Toll-Like Receptor 3 in a Phospholipid Bilayer. International Journal of Molecular Sciences 21:8, pages 2857.
Crossref
Bruna Jardim Quintanilha, Ludmila Rodrigues Pinto Ferreira, Frederico Moraes Ferreira, Edécio Cunha Neto, Geni Rodrigues Sampaio & Marcelo Macedo Rogero. (2020) Circulating plasma microRNAs dysregulation and metabolic endotoxemia induced by a high-fat high-saturated diet. Clinical Nutrition 39:2, pages 554-562.
Crossref
Jiang Chang, Xingdong Zhang & Kerong Dai. 2020. Bioactive Materials for Bone Regeneration. Bioactive Materials for Bone Regeneration 105 181 .
Sumana Narayanan & Joseph J. Skitzki. 2020. Cancer Immunology. Cancer Immunology 363 378 .
Mahmud Angrini, Aditi Varthaman & Isabelle Cremer. 2020. Tumor Microenvironment. Tumor Microenvironment 145 173 .
David C. McGowan. (2019) Latest Advances in Small Molecule TLR 7/8 Agonist Drug Research. Current Topics in Medicinal Chemistry 19:24, pages 2228-2238.
Crossref
Ana I. Matos, Barbara Carreira, Carina Peres, Liane I.F. Moura, João Conniot, Thibaut Fourniols, Anna Scomparin, Águeda Martínez-Barriocanal, Diego Arango, João P. Conde, Véronique Préat, Ronit Satchi-Fainaro & Helena F. Florindo. (2019) Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 307, pages 108-138.
Crossref
Brianna Atto, Mathew Suji Eapen, Pawan Sharma, Urs Frey, Alaina J. Ammit, James Markos, Collin Chia, Josie Larby, Greg Haug, Heinrich C. Weber, George Mabeza, Stephen Tristram, Stephen Myers, Dominic P. Geraghty, Katie L. Flanagan, Philip M. Hansbro & Sukhwinder Singh Sohal. (2019) New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways. Clinical Science 133:14, pages 1663-1703.
Crossref
Asma Achek, Masaud Shah, Ji Young Seo, Hyuk-Kwon Kwon, Xiangai Gui, Hyeon-Jun Shin, Eun-Young Cho, Byeong Sung Lee, Dong-Jin Kim, Sang Ho Lee, Tae Hyeon Yoo, Moon Suk Kim & Sangdun Choi. (2019) Linear and Rationally Designed Stapled Peptides Abrogate TLR4 Pathway and Relieve Inflammatory Symptoms in Rheumatoid Arthritis Rat Model. Journal of Medicinal Chemistry 62:14, pages 6495-6511.
Crossref
Łukasz Szylberg, Magdalena Bodnar, Anna Lebioda, Patrycja Krepska, Adam Kowalewski, Grzegorz Bręborowicz & Andrzej Marszałek. (2018) Differences in the Expression of TLR-2, NOD2, and NF-κB in Placenta Between Twins. Archivum Immunologiae et Therapiae Experimentalis 66:6, pages 463-470.
Crossref
Barnali Paul, Oindrila Rahaman, Swarnali Roy, Sourav Pal, Sohal Satish, Ayan Mukherjee, Amrit R. Ghosh, Deblina Raychaudhuri, Roopkatha Bhattacharya, Sunny Goon, Dipyaman Ganguly & Arindam Talukdar. (2018) Activity-guided development of potent and selective toll-like receptor 9 antagonists. European Journal of Medicinal Chemistry 159, pages 187-205.
Crossref
Darrick Carter, Neal van HoevenSusan Baldwin, Yotam Levin, Efrat Kochba, Al MagillNathalie CharlandNathalie Landry, Khin NuAude Frevol, Jill AshmanZachary K. SagawaAnna Marie BeckmannSteven G. Reed. (2018) The adjuvant GLA-AF enhances human intradermal vaccine responses. Science Advances 4:9.
Crossref
Li Nie, Shi-Yu Cai, Jian-Zhong Shao & Jiong Chen. (2018) Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals. Frontiers in Immunology 9.
Crossref
Marcelo Rogero & Philip Calder. (2018) Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids. Nutrients 10:4, pages 432.
Crossref
Balachandran Manavalan, Tae H. Shin, Myeong O. Kim & Gwang Lee. (2018) AIPpred: Sequence-Based Prediction of Anti-inflammatory Peptides Using Random Forest. Frontiers in Pharmacology 9.
Crossref
Darrick Carter, Malcolm S. Duthie & Steven G. Reed. 2020. Vaccination Strategies Against Highly Variable Pathogens. Vaccination Strategies Against Highly Variable Pathogens 103 127 .
Min Luo, Layla Z. Samandi, Zhaohui Wang, Zhijian J. Chen & Jinming Gao. (2017) Synthetic nanovaccines for immunotherapy. Journal of Controlled Release 263, pages 200-210.
Crossref
Leonardo Pedrazza, Talita Carneiro Brandão Pereira, Ana Lucia Abujamra, Fernanda Bordignon Nunes, Maurício Reis Bogo & Jarbas Rodrigues de Oliveira. (2017) Mesenchymal stem cells cannot affect mRNA expression of toll-like receptors in different tissues during sepsis. Inflammation Research 66:7, pages 547-551.
Crossref
T. Wang, R. He, J. Zhao, J.C. Mei, M.Z. Shao, Y. Pan, J. Zhang, H.S. Wu, M. Yu, W.C. Yan, L.M. Liu, F. Liu & W.P. Jia. (2017) Negative pressure wound therapy inhibits inflammation and upregulates activating transcription factor-3 and downregulates nuclear factor-κB in diabetic patients with foot ulcerations. Diabetes/Metabolism Research and Reviews 33:4, pages e2871.
Crossref
Luciana Cristina Mirotti, Ricardo Wesley Alberca Custódio, Eliane Gomes, Florencia Rammauro, Eliseu Frank de Araujo, Vera Lucia Garcia Calich & Momtchilo Russo. (2017) CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10. Frontiers in Immunology 8.
Crossref
Almudena Val-Blasco, Patricia Prieto, Silvia Gonzalez-Ramos, Gemma Benito, María Teresa Vallejo-Cremades, Ivette Pacheco, Pilar González-Peramato, Noelia Agra, Verónica Terrón, Carmen Delgado, Paloma Martín-Sanz, Lisardo Boscá & María Fernández-Velasco. (2017) NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes. Biochemical Journal 474:3, pages 399-410.
Crossref
Marion Dajon, Kristina Iribarren & Isabelle Cremer. (2017) Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword. Immunobiology 222:1, pages 89-100.
Crossref
Asma Achek, Dhanusha Yesudhas & Sangdun Choi. (2016) Toll-like receptors: promising therapeutic targets for inflammatory diseases. Archives of Pharmacal Research 39:8, pages 1032-1049.
Crossref
Y Yang, J Lv, S Jiang, Z Ma, D Wang, W Hu, C Deng, C Fan, S Di, Y Sun & W Yi. (2016) The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death & Disease 7:5, pages e2234-e2234.
Crossref
Mengchao Shi, Zetao Chen, Saba Farnaghi, Thor Friis, Xueli Mao, Yin Xiao & Chengtie Wu. (2016) Copper-doped mesoporous silica nanospheres, a promising immunomodulatory agent for inducing osteogenesis. Acta Biomaterialia 30, pages 334-344.
Crossref
Petr O. Ilyinskii & Lloyd P. M. Johnston. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders 249 278 .
Kai Wu, Hualei Wang, Huihui Sun & Dongzhi Wei. (2015) Efficient kinetic resolution of phenyl glycidyl ether by a novel epoxide hydrolase from Tsukamurella paurometabola. Applied Microbiology and Biotechnology 99:22, pages 9511-9521.
Crossref
Ji-Woong Kwon, Hyuk-Kwon Kwon, Hyeon-Jun Shin, Yong-Min Choi, Muhammad Ayaz Anwar & Sangdun Choi. (2015) Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-κB. Scientific Reports 5:1.
Crossref
Naresh Nalla, Preethi Pallavi, Bonam Srinivasa Reddy, Sreekanth Miryala, V. Naveen Kumar, Mohammed Mahboob & M. Sampath Kumar Halmuthur. (2015) Design, synthesis and immunological evaluation of 1,2,3-triazole-tethered carbohydrate–Pam 3 Cys conjugates as TLR2 agonists. Bioorganic & Medicinal Chemistry 23:17, pages 5846-5855.
Crossref
Deepa K. Ingawale, Satish K. Mandlik & Snehal S. Patel. (2015) An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance. Journal of Complementary and Integrative Medicine 12:1, pages 1-13.
Crossref
Julie A. Alosi, Scott W. Baldwin, Jacqueline Oxenberg & Joseph J. Skitzki. 2015. Cancer Immunology. Cancer Immunology 319 332 .
Song Yapan, Sun Liping, Guo Aizhen & Yang Liguo. (2014) Effects of toll-like receptor 2 gene mutation on resistance to bovine brucellosis. Livestock Science 170, pages 30-34.
Crossref
Nicole Cauchon, Haroutioun M. Hasséssian, Eric Turcotte, Roger Lecomte & Johan E. van Lier. (2014) Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model. Photochemical & Photobiological Sciences 13:10, pages 1434-1443.
Crossref
Genaro Alberto Paredes Juárez, Milica Spasojevic, Marijke M. Faas & Paul de Vos. (2014) Immunological and Technical Considerations in Application of Alginate-Based Microencapsulation Systems. Frontiers in Bioengineering and Biotechnology 2.
Crossref
Petr O. Ilyinskii, Christopher J. Roy, Conlin P. O’Neil, Erica A. Browning, Lynnelle A. Pittet, David H. Altreuter, Frank Alexis, Elena Tonti, Jinjun Shi, Pamela A. Basto, Matteo Iannacone, Aleksandar F. Radovic-Moreno, Robert S. Langer, Omid C. Farokhzad, Ulrich H. von Andrian, Lloyd P.M. Johnston & Takashi Kei Kishimoto. (2014) Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine 32:24, pages 2882-2895.
Crossref
Ajit G. Thomas, Cliona M. O’Driscoll, Joseph Bressler, Walter E. Kaufmann, Camilo J. Rojas & Barbara S. Slusher. (2014) Small molecule glutaminase inhibitors block glutamate release from stimulated microglia. Biochemical and Biophysical Research Communications 443:1, pages 32-36.
Crossref
Genaro A. Paredes-Juarez, Bart J. de Haan, Marijke M. Faas & Paul de Vos. (2013) The role of pathogen-associated molecular patterns in inflammatory responses against alginate based microcapsules. Journal of Controlled Release 172:3, pages 983-992.
Crossref
Anta Ngkelo & Ian M Adcock. (2013) New treatments for COPD. Current Opinion in Pharmacology 13:3, pages 362-369.
Crossref
Lisa A. Ridnour, Robert Y.S. Cheng, Christopher H. Switzer, Julie L. Heinecke, Stefan Ambs, Sharon Glynn, Howard A. Young, Giorgio Trinchieri & David A. Wink. (2013) Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment—Poor Prognosis or New Therapeutic Opportunity. Clinical Cancer Research 19:6, pages 1340-1346.
Crossref
Muhammad Ayaz Anwar, Shaherin Basith & Sangdun Choi. (2013) Negative regulatory approaches to the attenuation of Toll-like receptor signaling. Experimental & Molecular Medicine 45:2, pages e11-e11.
Crossref
Shaherin Basith, Balachandran Manavalan, Vijayakumar Gosu & Sangdun Choi. (2013) Evolutionary, Structural and Functional Interplay of the IκB Family Members. PLoS ONE 8:1, pages e54178.
Crossref
Fabrice Andre, Maria V. Dieci, Peter Dubsky, Christos Sotiriou, Giuseppe Curigliano, Carsten Denkert & Sherene Loi. (2013) Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer. Clinical Cancer Research 19:1, pages 28-33.
Crossref
Xiaohui Wang, Christina Smith & Hang Yin. (2013) Targeting Toll-like receptors with small molecule agents. Chemical Society Reviews 42:12, pages 4859.
Crossref
Tingting Deng, Xueying Feng, Peipei Liu, Keqin Yan, Yongmei Chen & Daishu Han. (2012) Toll‐like receptor 3 activation differentially regulates phagocytosis of bacteria and apoptotic neutrophils by mouse peritoneal macrophages. Immunology & Cell Biology 91:1, pages 52-59.
Crossref
J.F. Correia-Pinto, N. Csaba & M.J. Alonso. (2013) Vaccine delivery carriers: Insights and future perspectives. International Journal of Pharmaceutics 440:1, pages 27-38.
Crossref
Aurélie Ray, Marlène Cot, Germain Puzo, Martine Gilleron & Jérôme Nigou. (2013) Bacterial cell wall macroamphiphiles: Pathogen-/microbe-associated molecular patterns detected by mammalian innate immune system. Biochimie 95:1, pages 33-42.
Crossref
Soudeh Ghafouri-FardSomayyeh Ghafouri-Fard. (2012) siRNA and cancer immunotherapy. Immunotherapy 4:9, pages 907-917.
Crossref
M.W. Lawless & C.M. Greene. (2012) Toll-like receptor signalling in liver disease: ER stress the missing link?. Cytokine 59:2, pages 195-202.
Crossref
Shikha Tarang, Sushil Kumar & Surinder K. Batra. (2012) Mucins and Toll-like receptors: Kith and kin in infection and cancer. Cancer Letters 321:2, pages 110-119.
Crossref
Shaherin Basith, Balachandran Manavalan, Tae Hyeon Yoo, Sang Geon Kim & Sangdun Choi. (2012) Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense. Archives of Pharmacal Research 35:8, pages 1297-1316.
Crossref
Liping Sun, Yapan Song, Hasan Riaz, Hongzhen Yang, Guohua Hua, Aizhen Guo & Liguo Yang. (2012) Polymorphisms in toll-like receptor 1 and 9 genes and their association with tuberculosis susceptibility in Chinese Holstein cattle. Veterinary Immunology and Immunopathology 147:3-4, pages 195-201.
Crossref
Gillina F. G. Bezemer, Seil Sagar, Jeroen van Bergenhenegouwen, Niki A. Georgiou, Johan Garssen, Aletta D. Kraneveld & Gert Folkerts. (2012) Dual Role of Toll-Like Receptors in Asthma and Chronic Obstructive Pulmonary Disease. Pharmacological Reviews 64:2, pages 337-358.
Crossref
Jayalakshmi KrishnanSangdun Choi. (2012) Systems Biological Approaches Reveal Non-additive Responses and Multiple Crosstalk Mechanisms between TLR and GPCR Signaling. Genomics & Informatics 10:3, pages 153.
Crossref
F. G. Goh & K. S. Midwood. (2011) Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology 51:1, pages 7-23.
Crossref
Rajiv Gandhi Govindaraj, Balachandran Manavalan, Shaherin Basith & Sangdun Choi. (2011) Comparative Analysis of Species-Specific Ligand Recognition in Toll-Like Receptor 8 Signaling: A Hypothesis. PLoS ONE 6:9, pages e25118.
Crossref
Shaherin Basith, Balachandran Manavalan, Rajiv Gandhi Govindaraj & Sangdun Choi. (2011) In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L. PLoS ONE 6:8, pages e23989.
Crossref
NM Berezhnaia & RI Sepiashvili. (2011) Physiology of Toll-like receptors--regulators of natural and acquired immunity. Fiziolohichnyĭ zhurnal 5:57, pages 26-29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.